نتایج جستجو برای: new cancer drugs

تعداد نتایج: 2845475  

Abdollahipour Haghighi, Raziyeh, Arabsolghar, Rita, Golestani, Ali, Takhshid, Mohammad Ali,

Background & Objective: Cancer metastasis is the primary cause of cancer morbidity and mortality, it accounts for about 90% of cancer deaths. Cancer treatment has improved significantly, due to early detection and inhibition of cancer growth. The ability to invade and migrate is important in malignant tumor cells. The study of cell migration is valuable in cancer diagnosis, prognosis, drug dev...

Malignant tumors of head and neck carcinomas are the sixth most common type of cancer. Current systemic therapies for cancer show side effects in normal tissues and short-term efficacy due to drug resistance. Consequently, there is much interest in identifying new drugs for cancer treatment. Crocin (an active ingredient of saffron) has been shown to have cytotoxic effects on cancer cell lines. ...

Journal: :BMJ 2015
Donald W Light Joel Lexchin

Unlike most other diseases, cancer instils a special fear and “is treated as an evil, invincible predator, not just a disease.” The ability of drug companies to charge very high prices, even when most approved cancer drugs provide little gain for patients, drives much of the research, as desperate patients lead some governments and private insurers to pay whatever companies charge. Officials wi...

Journal: :gene, cell and tissue 0
ebrahim eskandari-nasab genetic of non-communicable disease research center, zahedan university of medical sciences, zahedan, ir iran fatemeh dahmardeh department of biology, faculty of sciences, university of zabol, zabol, ir iran alireza rezaeifar department of clinical biochemistry, school of medicine, zabol university of medical sciences, zabol, ir iran; department of clinical biochemistry, school of medicine, zabol university of medical sciences, zabol, ir iran. tel: +98-5432253535, fax: +98-5432253537 tayebeh dahmardeh department of biology, faculty of sciences, ferdowsi university of mashhad, mashhad, ir iran

conclusions since telomerase is expressed in 90% of cancer cells, its inhibition can be considered as a goal of cancer treatment. results about 90% of cancers need a high level of this enzyme to continue cell multiplication. since this enzyme set is absent in normal cells, or present at a very low level, use of telomerase inhibitors cannot have significant effects on normal cells. evidence acqu...

Journal: :JNCI Journal of the National Cancer Institute 2012

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید